Anti-cancer effects of the combined treatment of trastuzumab and decoy oligodeoxynucleotides to target STAT3 transcription factor on SK-BR-3 breast cancer cell line

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

JOHARI BEHROOZ; GHORBANI ROGHAYEH; HEIDARI SARA; Rashidi Somayyeh; MADANCHI HAMID

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Koomesh Year:2022 | Volume: | Issue: Page(s): 71-82

Download Full-Text

Persian Verion

View:

Download:

Cites:

Information Journal Paper

Title

Anti-cancer effects of the combined treatment of trastuzumab and decoy oligodeoxynucleotides to target STAT3 transcription factor on SK-BR-3 breast cancer cell line

Author(s)

Keywords

Breast cancer

HER2 receptor

Oligodeoxynucleotide decoy

STAT3 transcription factor

Apoptosis

Cell migration

Abstract

Introduction: Breast cancer is the most common malignancy in the female population and is the leading cause of death. Surgery, chemotherapy, radiotherapy, and monoclonal antibody (trastuzumab) therapy are common and standard treatments for this cancer. However, there are significant limitations in the treatment of this disease by using regular methods. Given the role of transcription factors (TFs) in gene expression, differentiation therapy, and many cancer signaling pathways, in the present study, the effect of combined treatment of trastuzumab (Herceptin) and decoy oligodeoxynucleotides to target the STAT3 transcription factor on inhibition of HER2 positive SK-BR-3 cell line growth was investigated. Materials and Methods: At first, different concentrations of Trastuzumab were prepared from 0. 1 to 100 μ, g/mL. In this way, the decoy and scramble oligodeoxynucleotides were designed and synthesized to target the STAT3 transcription factor. The transfection efficiency and combined effects of trastuzumab with decoy oligos on cell viability, Apoptosis, and Cell migration inhibition were evaluated. Results: The results showed that oligodeoxynucleotides labeled with Cy3 fluorophore (300 nM) enter the cells with high efficiency (81. 7±, 6. 9%). Combined treatment of cells by trastuzumab (10 μ, g/mL) along with decoy oligodeoxynucleotides (100 nM) led to a decrease in cell viability (58. 86±, 2. 71%), increased Apoptosis (24. 54±, 4. 83%) and inhibited Cell migration (45. 95±, 4. 21%). Conclusion: The results from this study showed the anticancer effects of combination therapy using trastuzumab with decoy oligodeoxynucleotides to target the STAT3 transcription factor in SK-BR-3 cells. Therefore, it seems that this strategy can be used as an adjunct to common treatments for Breast cancer.

Cites

Upregulation of Osteopontin in Metastatic Mouse Breast Cancer Cells

References

Application of decoy oligodeoxynucleotides strategy for inhibition of cell growth and reduction of metastatic properties in nonresistant and erlotinib-resistant SW480 cell line

Cite

APA: Copy

JOHARI, BEHROOZ, GHORBANI, ROGHAYEH, HEIDARI, SARA, Rashidi, Somayyeh, & MADANCHI, HAMID. (2023). Anti-cancer effects of the combined treatment of trastuzumab and decoy oligodeoxynucleotides to target STAT3 transcription factor on SK-BR-3 breast cancer cell line. KOOMESH, 25(1 (93) ), 71-82. SID. https://sid.ir/paper/1134636/en

Vancouver: Copy

JOHARI BEHROOZ, GHORBANI ROGHAYEH, HEIDARI SARA, Rashidi Somayyeh, MADANCHI HAMID. Anti-cancer effects of the combined treatment of trastuzumab and decoy oligodeoxynucleotides to target STAT3 transcription factor on SK-BR-3 breast cancer cell line. KOOMESH[Internet]. 2023;25(1 (93) ):71-82. Available from: https://sid.ir/paper/1134636/en

IEEE: Copy

BEHROOZ JOHARI, ROGHAYEH GHORBANI, SARA HEIDARI, Somayyeh Rashidi, and HAMID MADANCHI, “Anti-cancer effects of the combined treatment of trastuzumab and decoy oligodeoxynucleotides to target STAT3 transcription factor on SK-BR-3 breast cancer cell line,” KOOMESH, vol. 25, no. 1 (93) , pp. 71–82, 2023, [Online]. Available: https://sid.ir/paper/1134636/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops